Alessandro Di Federico, Medical Oncologist and Ph.D. student at the University of Bologna, shared a post on LinkedIn:
“A short summary of American Society of Clinical Oncology (ASCO) 2026 highlights about NSCLC targeted therapy.”
Other articles about Lung Cancer on OncoDaily.